Last reviewed · How we verify

Azatidine (AZATADINE)

FDA-approved approved Small molecule Quality 35/100

Azatidine, also known as azatadine, is a small molecule drug that targets the histamine H1 receptor. It was originally developed and is currently owned by a pharmaceutical company. Azatidine was FDA approved in 1977 for various allergic conditions, including allergic conjunctivitis, rhinitis, and anaphylaxis. The drug is off-patent, meaning it is no longer protected by patents, and there are no generic manufacturers. As an off-patent medication, its commercial status is uncertain.

At a glance

Generic nameAZATADINE
Drug classazatadine
TargetHistamine H1 receptor
ModalitySmall molecule
Therapeutic areaInfectious Disease
PhaseFDA-approved
First approval1977

Approved indications

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions